LLY Eli Lilly & Co

Five-factor quant read, peer ranking, and the analyst team's own call.

7.8

composite/ 10

Factor Scores Peer Comparison Desk Analysis

Value computed

8.2

priced for 25.9% growth vs 31.7% delivered · +34% to base-case fair value

Quality computed

7.9

Piotroski 6/8 · Altman safe zone · ROE 78% on 4.2x leverage · interest covered 38x

Momentum rank

6.0

shallow recent drawdowns · low-beta - defensive profile

Defensive rank

9.0

Tactical rank

8.0

Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper. Deciles as of 2026-09-02.

Peer comparison

Composite score against sector peers · 6 names

8.2

7.8

6.4

5.7

5.6

5.3

LLY ranks #2 of 6 · peer average 6.5

No current desk call on LLY. The factor scores above are computed; a full analysis is four analyst desks, a bull-vs-bear debate and a risk committee, and takes about three minutes.

Run the analyst team on LLY →

Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.